A Dark Vector Cognition product

Item 16. Form 10-K Summary

2K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange

Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned,

thereunto duly authorized.

Henry Schein, Inc.

By: /s/ STANLEY M. BERGMAN

Stanley M. Bergman

Chairman and Chief Executive Officer

February 21, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934, this

report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on

the dates indicated.

Signature

Capacity

Date

/s/ STANLEY M. BERGMAN

Chairman, Chief Executive Officer

February 21, 2023

Stanley M. Bergman

and Director (principal executive officer)

/s/ RONALD N. SOUTH

Senior Vice President, Chief

Financial Officer

February 21, 2023

Ronald N. South

(principal financial and accounting officer)

/s/ JAMES P.

BRESLAWSKI

Vice Chairman, President

and Director

February 21, 2023

James P.

Breslawski

/s/ MARK E. MLOTEK

Director

February 21, 2023

Mark E. Mlotek

/s/ MOHAMAD ALI

Director

February 21, 2023

Mohamad Ali

/s/ DEBORAH DERBY

Director

February 21, 2023

Deborah Derby

/s/ JOSEPH L. HERRING

Director

February 21, 2023

Joseph L. Herring

/s/ KURT P.

KUEHN

Director

February 21, 2023

Kurt P.

Kuehn

/s/ PHILIP A. LASKAWY

Director

February 21, 2023

Philip A. Laskawy

/s/ ANNE H. MARGULIES

Director

February 21, 2023

Anne H. Margulies

/s/ STEVEN PALADINO

Director

February 21, 2023

Steven Paladino

/s/ CAROL RAPHAEL

Director

February 21, 2023

Carol Raphael

/s/ SCOTT SEROTA

Director

February 21, 2023

Scott Serota

/s/ BRADLEY T. SHEARES,

PH. D.

Director

February 21, 2023

Bradley T.

Sheares, Ph. D.

/s/ REED V.

TUCKSON, M.D., FACP

Director

February 21, 2023

Reed V.

Tuckson, M.D., FACP

Previous: Item 15. Exhibits, Financial Statement Schedules